Latest Breaking News On - Danieln swisher jr - Page 2 : comparemela.com

HC Wainwright Reaffirms Buy Rating for Corcept Therapeutics (NASDAQ:CORT)

HC Wainwright Reaffirms Buy Rating for Corcept Therapeutics (NASDAQ:CORT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDanieln swisher jrJoseph douglas lyonNorden groupAllspring global investments holdingsCorcept therapeutics incorporatedRaymond james financial services advisors incSecurities exchange commissionMilestone asset managementCambridge investment research advisors incCorcept therapeuticsFree reportGet free reportExchange commissionDirector daniel

Corcept Therapeutics (CORT) Buy Rating Reaffirmed at HC Wainwright

Corcept Therapeutics (CORT) Buy Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSean maduckDanieln swisher jrCambridge investment research advisors incIllinois municipal retirement fundLinden thomas advisory servicesSecurities exchange commissionCorcept therapeutics incorporatedHightower advisorsAllspring global investments holdingsCorcept therapeuticsFree reportGet free reportDirector danielExchange commission

Linden Thomas Advisory Services LLC Has $1 84 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Linden Thomas Advisory Services LLC Has $1 84 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDanieln swisher jrZurcher kantonalbank zurich cantonalbankJoseph douglas lyonCorcept therapeutics company profileCorcept therapeutics incorporatedSecurities exchange commissionCornerstone investment partnersCornercap investment counsel incMackenzie financial corpLinden thomas advisory servicesFree reportThomas advisory servicesCorcept therapeuticsInvestment partnersKantonalbank zurich cantonalbank

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3 3%

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph douglas lyonDanieln swisher jrMilestone asset managementAlphamark advisorsAllspring global investments holdingsNorden groupCorcept therapeutics incorporatedRaymond james financial services advisors incGet free reportCorcept therapeuticsTruist financialDirector danielDouglas lyonAsset managementJames financial services advisors

Zacks Research Comments on Corcept Therapeutics Incorporated s Q3 2025 Earnings (NASDAQ:CORT)

Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Corcept Therapeutics in a research report issued on Wednesday, April 17th. Zacks Research analyst K. Das now forecasts that the biotechnology company will earn $0.26 per share for the quarter, up […]

United statesJoseph douglas lyonDanieln swisher jrSecurities exchange commissionZacks researchCorcept therapeutics incorporatedFintrust capital advisorsCorcept therapeutics company profileLazard asset managementInvestment advisersFree reportCorcept therapeuticsCorcept therapeuticTruist financialGet free reportDouglas lyon